HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
The action of GLP-1(7-36) on cells may be more indirect, such as through the influence on hormones secreted by and cells (insulin and glucagon), which indirectly affects cell somatostatin secretion
[9] Semaglutide Efficacy at Low Doses: Slower Progress, Better Comfort Semaglutide (Ozempic/Wegovy) is the most common drug for microdosing, largely because its pen design allows for the click method, a technique I explain step-by-step later in the article
[PubMed] [Google Scholar] 10.Maquart FX, Bellon G, Chaqour B, et al
.png)
